Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 877.00
+0.70 (0.08%)
Apr 3, 2026, 1:44 PM IDT
Epitomee Medical Revenue
In the year 2025, Epitomee Medical had annual revenue of $213.00K USD. Epitomee Medical had revenue of $213.00K in the half year ending December 31, 2025, a decrease of -97.87%.
Revenue
$213.00K
Revenue Growth
n/a
P/S Ratio
388.58
Revenue / Employee
$5.07K
Employees
42
Market Cap
263.86M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 213.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 10.00M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Novolog (Pharm-Up 1966) | 1.81B |
| Ilex Medical | 930.83M |
| Kamada | 575.31M |
| Rekah Pharmaceutical Industry | 300.24M |
| InterCure | 243.12M |
| BrainsWay | 166.49M |